Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Favipiravir in High Risk COVID-19 Patients: A Randomised, Open-label, Multicenter Clinical Trial

NCT04818320 is registered in ClinicalTrials.gov with Penang Hospital, Malaysia as lead sponsor.

NCT NCT04818320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04818320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Favipiravir in High Risk COVID-19 Patients: A Randomised, Open-label, Multicenter Clinical Trial
Lead sponsor
Penang Hospital, Malaysia
Phase
Phase 3
Overall status
Completed
Start date
February 16, 2021
Completion date
July 13, 2021
Enrollment
500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19